Interstitial Lung Disease (ILD) has many lung disorders that fall under that term. One of them Idiopathic Pulmonary Fibrosis (IPF), is the most common of these disorders. Asbestosis is diffuse pulmonary fibrosis resulting in a slowly progressing disease that can take from 15 to 40 years after exposure to be encountered physical symptoms. And while in most developing countries it has been banned, the exposure-related diagnoses are still being cared for.
Ads by Google
Chronic coughing should be investigated by a trip to the doctor as it could be a sign of something deadly: the danger of asbestos.
Scientists may have found a key molecule that can help doctors detect mesothelioma cancer in asbestos-exposed people before it advances into later stages.
Let's start with Mesothelioma hope. A new drug mixture of tremelimumab and Imfinzi (durvalumab) show encouraging results in the first phase II mesothelioma clinical trial examining this combination. The study, which included 40 mesothelioma patients in Italy, was published in the June 2018 edition of The Lancet Respiratory Medicine.
The study used established methods to see if specific types of nanotubes have the potential to cause mesothelioma -- a cancer of the lung lining that can take 30-40 years to appear following exposure.
Vinflunine shows encouragin sings for treatment in Malignant Pleural Mesothelioma.
Minnesota Department of Health has identified six additional cases of mesothelioma in a group of 72,000 people who worked in the state's iron mining industry between the 1930s and 1982.
New York Mesothelioma Lawyers File Lawsuit in Syracuse, NY After Rare Asbestos-Related Cancer Claims Third Family Member.
Rosetta Genomics has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
People with mesothelioma have a higher survival rate when treated with a combination of two cancer drugs.
The Mesothelioma conference aims to educate patients about the disease.
Mesothelioma cancer is associated with exposure to volcanic mineral in Turkey.
Chemotherapy prior to the onset of mesothelioma symptoms improves outcomes compared to administering chemotherapy once symptoms have occurred in patients with mesothelioma.
Californians are at increased risk for developing malignant mesothelioma, a serious cancer of the membrane covering the lung.
The current model for determining the prognosis for malignant pleural mesothelioma is a valid tool.
The majority of individuals who develop malignant pleural mesothelioma have a history of chronic exposure to asbestos. Research continues to find treatment options for mesothelioma.
Residents participating in Mesothelioma Applied Research Foundation funded research into Mesothelioma Serum Marker.